FM
BSX icon

Freemont Management’s Boston Scientific BSX Stock Holding History

Freemont Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,500
Closed -$471K – 40
2026
Q1 		$471K Sell
7,500
-800
-10% -$64K 0.07% 131
2025
Q4 		$791K Buy
8,300
+5,500
+196% +$539K 0.14% 111
2025
Q3 		$273K Sell
2,800
-21,100
-88% -$2.19M 0.14% 91
2025
Q2 		$2.57M Buy
23,900
+5,600
+31% +$567K 0.38% 66
2025
Q1 		$1.85M Buy
+18,300
New +$1.84M 0.61% 53

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Freemont Management's BSX Position: Q2 2026 in Review

Freemont Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,500 shares — an estimated $471K sold.

Freemont Management first reported a position in BSX in Q1 2025 and held it in 5 quarters. The position peaked at $2.57M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Freemont Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Freemont Management sold 7,500 Boston Scientific shares in Q2 2026, an estimated $471K.
  • Freemont Management first reported a position in Boston Scientific in Q1 2025 and held it in 5 quarters.
  • Freemont Management's Boston Scientific position peaked at $2.57M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Freemont Management's 13F filing for Q2 2026, filed 11 Aug 2026.